Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCirata Regulatory News (CRTA)

Share Price Information for Cirata (CRTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 68.50
Ask: 70.50
Change: 3.90 (5.99%)
Spread: 2.00 (2.92%)
Open: 65.50
High: 70.50
Low: 65.50
Prev. Close: 65.10
CRTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Annual General Meeting

14 May 2024 15:28

RNS Number : 4155O
Cirata PLC
14 May 2024
 

14 May 2024

 

Cirata plc

All Resolutions pass at Cirata AGM

("Cirata" or the "Company")

Result of Annual General Meeting

 

Cirata plc (LSE: CRTA), is pleased to announce that all resolutions set out in the Notice of Meeting and put to the Annual General Meeting ("AGM") of the Company, held at Brown Rudnick LLP, 8 Clifford Street, London W1S 2LQ on 14 May 2024 were duly passed.

Resolutions 1- 11 were passed as Ordinary Resolutions (requiring at least a 50% majority to be passed) and resolutions 12 - 13 were passed as Special Resolutions (requiring at least a 75% majority to be passed). The results are set out in detail below.

 

Resolution

Votes For

%

Votes Against

%

Total Votes Cast (Excluding Withheld)

% of ISC Voted4

Votes Withheld

1.

That the Company's FY23 financial statements be adopted

49,145,684

99.89

56,471

0.11

49,202,155

42.48

170,675

2.

That Ken Lever be elected as a Director of the Company

49,202,155

100

0

0

49,202,155

42.48

170,675

3.

That Stephen Kelly be elected as a Director of the Company

49,202,155

100

0

0

49,202,155

42.48

170,675

4.

That Ijoma Maluza be elected as a Director of the Company

49,202,155

100

0

0

49,202,155

42.48

170,675

5.

That Peter Lees be re-elected as a Director of the Company

49,202,155

100

0

0

49,202,155

42.48

170,675

6.

That Xenia Walters be elected as a Director of the Company

49,202,155

100

0

0

49,202,155

42.48

170,675

7.

That Chris Baker be elected as a Director of the Company

49,202,155

100

0

0

49,202,155

42.48

170,675

8.

That Crowe UK LLP be re-appointed as auditors of the Company

49,202,155

100

0

0

49,202,155

42.48

170,675

9.

That the Directors be authorised to determine the remuneration of the auditor

49,202,155

100

0

0

49,202,155

42.48

170,675

10.

That the Directors are authorised to allot securities

49,196,898

99.99

5,257

0.01

49,202,155

42.48

170,675

11.

That the Company may hold treasury shares in accordance with the Law and the Articles

49,197,155

99.99

5,000

0.01

49,202,155

42.48

170,675

12.

Disapplication of pre-emption rights

49,200,785

99.99

1,370

0.01

49,202,155

42.48

170,675

13.

That the Directors are authorised to make market purchases of its own shares

49,202,155

100

0

0

49,202,155

42.48

170,675

 

NOTES:

1. Proxy appointments which gave discretion to the Chairman of the Meeting have been included

in the "For" total for the appropriate resolution.

2. Votes "For" and "Against" any resolution are expressed as a percentage (rounded to two

decimal places) of votes validly cast for that resolution.

3. The full text of the resolutions passed at the Meeting can be found in the Notice of Meeting

which is available on the Company's website at: http://www.cirata.com.

4. Based on total issued share capital as at 12 April 2024 of 115,827,302 Ordinary shares.

 

 

The person responsible for arranging the release of this announcement on behalf of Cirata plc is Larry Webster, Company Secretary. 

 

 

For further information, please contact: 

 

Cirata

Via FTI Consulting

Stephen Kelly, Chief Executive Officer

Ijoma Maluza, Chief Financial Officer

Daniel Hayes, Investor Relations

 

 

FTI Consulting

+44 (0)20 3727 1137

Matt Dixon / Kwaku Aning / Usama Ali

 

 

Stifel (Nomad and Joint Broker)

+44 (0)20 7710 7600

Fred Walsh / Richard Short 

 

 

Liberum (Joint Broker)

+44 (0)20 3100 2000

Max Jones / Edward Mansfield / John More

 

 

About Cirata

 

Cirata accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated. For more information about Cirata, visit www.cirata.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGQKQBBQBKDPPD
Date   Source Headline
21st May 20247:00 amRNSOPPO Contract Renewal
14th May 20243:28 pmRNSResult of Annual General Meeting
29th Apr 20245:01 pmRNSFurther re: Annual Report & Notice of AGM
24th Apr 20247:00 amRNSDirectorate Change
17th Apr 20243:05 pmRNSAnnual Report & Notice of AGM
9th Apr 20247:00 amRNSQ1 FY24 Trading Update
4th Apr 20247:00 amRNSFinal Results
6th Mar 20245:19 pmRNSHolding(s) in Company
4th Mar 20242:53 pmRNSHolding(s) in Company
21st Feb 20241:27 pmRNSHolding(s) in Company
15th Feb 20244:27 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSChair appointment
9th Jan 20247:00 amRNSTrading Update
4th Jan 20243:10 pmRNSTotal Voting Rights
4th Jan 20242:41 pmRNSHolding(s) in Company
3rd Jan 20245:40 pmRNSHolding(s) in Company
2nd Jan 20249:32 amRNSNotice of Q4 FY23 Trading Update
14th Dec 20236:12 pmRNSBlock Listing Application
12th Dec 20235:32 pmRNSGrant of Share Options to PDMRs
12th Dec 20238:29 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSTotal Voting Rights
5th Dec 202310:25 amRNSHolding(s) in Company
24th Nov 20235:40 pmRNSDirector/PDMR Shareholding
23rd Nov 202310:08 amRNSHolding(s) in Company
21st Nov 20235:41 pmRNSHolding(s) in Company
21st Nov 20231:28 pmRNSHolding(s) in Company
21st Nov 20237:00 amRNSDirector/PDMR Shareholding
17th Nov 20235:54 pmRNSDirector/PDMR Shareholding
8th Nov 20231:18 pmRNSHolding(s) in Company
7th Nov 20232:39 pmRNSTotal Voting Rights
2nd Nov 20237:00 amRNSChange of Auditor
27th Oct 20235:12 pmRNSHolding(s) in Company
18th Oct 20237:00 amRNSTrading Update and Outlook
6th Oct 202312:12 pmRNSHCSC renews contract
6th Oct 202311:24 amRNSHolding(s) in Company
5th Oct 202310:39 amRNSNotice of Q3 FY23 Trading Update
5th Oct 20239:00 amRNSNatWest expands contract
5th Oct 20237:00 amRNSConfirmation of Ticker Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.